On ECHEMI
Home > Drugs > Lambert-Eaton syndrome
Lambert-Eaton syndrome
Lambert-Eaton syndrome, also known as myasthenia-like syndrome, is a special type of myasthenia and autoimmune disease involving cholinergic synapses. First described by Lambert, Eaton and Rooke (1956), the disease is characterized by weakness and fatigue of the proximal limb muscle groups. After a short and forceful contraction of the affected muscle, the muscle strength is enhanced, and after continuous contraction, there is pathological fatigue. Lambert-Eaton syndrome is a transmission disorder at the neuromuscular junction. It is caused by the loss of presynaptic calcium channels by anti-P/Q-type voltage-gated calcium ion channel (P/Q-type VGCC) antibodies, which reduces the number of minimum release units of acetylcholine released at the presynaptic membrane and causes myasthenia.
  • Site of disease:

    Brain Immune System Muscle
  • Infectious :

    Not contagious
  • Frequent population:

    More than 50 to 70 years old, mostly male
  • Related symptoms:

    Fatigue muscle weakness dysarthria dysphagia
Related Drugs
Anshen Bunao Liquid
Manufacturer:

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Zhibao Sanbian Pills
Manufacturer:

Yantai Zhongya Zhibao Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.